
Nepicastat hydrochloride
CAS No. 170151-24-3
Nepicastat hydrochloride ( SYN-117 hydrochloride | RS-25560-197 hydrochloride )
产品货号. M12599 CAS No. 170151-24-3
Nepicastat (RS-25560-197, SYN-117) 是一种有效的、选择性的、口服活性的多巴胺-β-羟化酶 (DBH) 抑制剂,对牛和人 DBH 的 IC50 分别为 8.5 和 9.0 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥421 | 有现货 |
![]() ![]() |
10MG | ¥721 | 有现货 |
![]() ![]() |
25MG | ¥1288 | 有现货 |
![]() ![]() |
50MG | ¥2195 | 有现货 |
![]() ![]() |
100MG | ¥3856 | 有现货 |
![]() ![]() |
500MG | ¥8505 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Nepicastat hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Nepicastat (RS-25560-197, SYN-117) 是一种有效的、选择性的、口服活性的多巴胺-β-羟化酶 (DBH) 抑制剂,对牛和人 DBH 的 IC50 分别为 8.5 和 9.0 nM。
-
产品描述Nepicastat (RS-25560-197, SYN-117) is a potent, selective, orally active inhibitor of dopamine-beta-hydroxylase (DBH) with IC50 of 8.5 and 9.0 nM for bovine and human DBH, respectively; Nepicastat is 2-3 fold more potent than the corresponding R-enantiomer (RS-25560-198); produces dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery, left ventricle and cerebral cortex in spontaneously hypertensive rats.Hypertension Discontinued(In Vivo):Nepicastat hydrochloride (SYN-117 hydrochloride) (3-100 mg/kg; p.o.; three consecutive times, 12 hours apart times) produces dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery (mesenteric or renal), left ventricle.
-
体外实验——
-
体内实验Nepicastat hydrochloride (SYN-117 hydrochloride) (3-100 mg/kg; p.o.; three consecutive times, 12 hours apart times) produces dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery (mesenteric or renal), left ventricle. Animal Model:15-16 weeks male spontaneously hypertensive rats (SHRs)Dosage:3, 10, 30, 100 mg/kg Administration:Oral administration; three consecutive times, 12 hours apart Result:Produced dose-dependent decreases in noradrenaline content, increases in dopamine content and increases in dopamine/noradrenaline ratio in the artery (mesenteric or renal), left ventricle and cerebral cortex.
-
同义词SYN-117 hydrochloride | RS-25560-197 hydrochloride
-
通路Metabolic Enzyme/Protease
-
靶点Dopamine beta-hydroxylase
-
受体Dopamineβ-hydroxylase
-
研究领域Cardiovascular Disease
-
适应症Hypertension
化学信息
-
CAS Number170151-24-3
-
分子量331.8
-
分子式C14H16ClF2N3S
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 31 mg/mL
-
SMILESC1CC2=C(CC1N3C(=CNC3=S)CN)C=C(C=C2F)F.Cl
-
化学全称2H-Imidazole-2-thione, 5-(aminomethyl)-1-[(2S)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-, hydrochloride (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Stanley WC, et al. Br J Pharmacol. 1997 Aug;121(8):1803-9.
2. Stanley WC, et al. J Cardiovasc Pharmacol. 1998 Jun;31(6):963-70.
3. Sabbah HN, et al. Circulation. 2000 Oct 17;102(16):1990-5.
4. Schroeder JP, et al. Neuropsychopharmacology. 2010 Nov;35(12):2440-9.
产品手册




关联产品
-
Nepicastat
Nepicastat (RS-25560-197, SYN-117) 是一种有效的、选择性的、口服活性的多巴胺-β-羟化酶 (DBH) 抑制剂,对牛和人 DBH 的 IC50 分别为 8.5 和 9.0 nM。
-
Nepicastat hydrochlo...
Nepicastat (RS-25560-197, SYN-117) 是一种有效的、选择性的、口服活性的多巴胺-β-羟化酶 (DBH) 抑制剂,对牛和人 DBH 的 IC50 分别为 8.5 和 9.0 nM。